Nathaniel Macapagal

Nathaniel Macapagal has extensive work experience in the biotechnology and pharmaceutical industry. Nathaniel is currently the Director of Process and Drug Product Development at BioFactura, Inc. Prior to this, they held the position of Associate Director of Process Development at BioFactura, Inc.

Before joining BioFactura, Inc., Nathaniel worked at AstraZeneca for nine years, starting as an Associate Scientist II and progressing to Scientist I. During their time at AstraZeneca, they completed purification process development for multiple protein therapeutics, including serving as the CMC purification lead for several projects. Nathaniel also developed unit operations for the purification processes of various drugs.

Nathaniel's earlier experience includes working at Amplimmune, which was later acquired by Medimmune/AstraZeneca, where they held the roles of Associate Scientist and Scientist. At Amplimmune, they were involved in cloning recombinant therapeutic genes and developing purification processes.

Nathaniel also worked as a Group Leader of Monoclonal Antibody Bioprocessing at Strategic Diagnostics, where they managed a team of scientists and completed numerous purification projects.

Nathaniel began their career as a Research Assistant at the University of Delaware, where they studied protein folding and developed the bacterial fermentation, refolding, and purification processes for a single-chain antibody.

Nathaniel also worked as a Process Validation Engineer at Wyeth Vaccines Research, which is now Pfizer, early in their career.

Overall, Nathaniel Macapagal has a diverse background in process development, purification, and bioprocessing, with experience at various stages of drug development, from research to commercial production.

Nathaniel Macapagal has a strong educational background with degrees in Chemical Engineering and an upcoming Master of Business Administration (MBA). Nathaniel began their higher education journey at Rutgers University, where they obtained a Bachelor of Science (B.S.) degree in Chemical Engineering from 1995 to 1999. After obtaining their undergraduate degree, Nathaniel pursued further specialization in the field by pursuing a Master of Science (MS) degree in Chemical Engineering from the University of Delaware. This program spanned from 2002 to 2006.

Displaying a commitment to continuous learning and career advancement, Nathaniel Macapagal is currently in the process of completing their Master of Business Administration (MBA) degree at The Johns Hopkins University. This program, specializing in Entrepreneurship, Innovation, and Technology, commenced in 2022 and is expected to be completed by 2025.

Based on the provided information, it can be inferred that Nathaniel Macapagal has a strong foundation in Chemical Engineering, supplemented by their ongoing studies in business administration. However, without further data, it is not possible to determine Nathaniel's profession or their intentions for combining these fields of study.